These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 33832819)

  • 1. Consensus recommendations for the classification and long-term follow up of infants who screen positive for Krabbe Disease.
    Thompson-Stone R; Ream MA; Gelb M; Matern D; Orsini JJ; Levy PA; Rubin JP; Wenger DA; Burton BK; Escolar ML; Kurtzberg J
    Mol Genet Metab; 2021; 134(1-2):53-59. PubMed ID: 33832819
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The critical role of psychosine in screening, diagnosis, and monitoring of Krabbe disease.
    Guenzel AJ; Turgeon CT; Nickander KK; White AL; Peck DS; Pino GB; Studinski AL; Prasad VK; Kurtzberg J; Escolar ML; Lasio MLD; Pellegrino JE; Sakonju A; Hickey RE; Shallow NM; Ream MA; Orsini JJ; Gelb MH; Raymond K; Gavrilov DK; Oglesbee D; Rinaldo P; Tortorelli S; Matern D
    Genet Med; 2020 Jun; 22(6):1108-1118. PubMed ID: 32089546
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Psychosine, a marker of Krabbe phenotype and treatment effect.
    Escolar ML; Kiely BT; Shawgo E; Hong X; Gelb MH; Orsini JJ; Matern D; Poe MD
    Mol Genet Metab; 2017 Jul; 121(3):271-278. PubMed ID: 28579020
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Measurement of psychosine in dried blood spots--a possible improvement to newborn screening programs for Krabbe disease.
    Turgeon CT; Orsini JJ; Sanders KA; Magera MJ; Langan TJ; Escolar ML; Duffner P; Oglesbee D; Gavrilov D; Tortorelli S; Rinaldo P; Raymond K; Matern D
    J Inherit Metab Dis; 2015 Sep; 38(5):923-9. PubMed ID: 25762404
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Development of a newborn screening tool based on bivariate normal limits: using psychosine and galactocerebrosidase determination on dried blood spots to predict Krabbe disease.
    Langan TJ; Orsini JJ; Jalal K; Barczykowski AL; Escolar ML; Poe MD; Biski CK; Carter RL
    Genet Med; 2019 Jul; 21(7):1644-1651. PubMed ID: 30546085
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Determination of psychosine concentration in dried blood spots from newborns that were identified via newborn screening to be at risk for Krabbe disease.
    Chuang WL; Pacheco J; Zhang XK; Martin MM; Biski CK; Keutzer JM; Wenger DA; Caggana M; Orsini JJ
    Clin Chim Acta; 2013 Apr; 419():73-6. PubMed ID: 23419961
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Consensus guidelines for newborn screening, diagnosis and treatment of infantile Krabbe disease.
    Kwon JM; Matern D; Kurtzberg J; Wrabetz L; Gelb MH; Wenger DA; Ficicioglu C; Waldman AT; Burton BK; Hopkins PV; Orsini JJ
    Orphanet J Rare Dis; 2018 Feb; 13(1):30. PubMed ID: 29391017
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Newborn screening for Krabbe disease in New York State: the first eight years' experience.
    Orsini JJ; Kay DM; Saavedra-Matiz CA; Wenger DA; Duffner PK; Erbe RW; Biski C; Martin M; Krein LM; Nichols M; Kurtzberg J; Escolar ML; Adams DJ; Arnold GL; Iglesias A; Galvin-Parton P; Kronn DF; Kwon JM; Levy PA; Pellegrino JE; Shur N; Wasserstein MP; Caggana M;
    Genet Med; 2016 Mar; 18(3):239-48. PubMed ID: 26795590
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Expression of individual mutations and haplotypes in the galactocerebrosidase gene identified by the newborn screening program in New York State and in confirmed cases of Krabbe's disease.
    Saavedra-Matiz CA; Luzi P; Nichols M; Orsini JJ; Caggana M; Wenger DA
    J Neurosci Res; 2016 Nov; 94(11):1076-83. PubMed ID: 27638593
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Rare Saposin A deficiency: Novel variant and psychosine analysis.
    Calderwood L; Wenger DA; Matern D; Dahmoush H; Watiker V; Lee C
    Mol Genet Metab; 2020 Feb; 129(2):161-164. PubMed ID: 31439510
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Can psychosine and galactocerebrosidase activity predict early-infantile Krabbe's disease presymptomatically?
    Carter RL; Wrabetz L; Jalal K; Orsini JJ; Barczykowski AL; Matern D; Langan TJ
    J Neurosci Res; 2016 Nov; 94(11):1084-93. PubMed ID: 27638594
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Krabbe leukodystrophy in a selected population with high rate of late onset forms: longer survival linked to c.121G>A (p.Gly41Ser) mutation.
    Fiumara A; Barone R; Arena A; Filocamo M; Lissens W; Pavone L; Sorge G
    Clin Genet; 2011 Nov; 80(5):452-8. PubMed ID: 21070211
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Newborn Screening for Krabbe Disease-Illinois Experience: Role of Psychosine in Diagnosis of the Disease.
    Basheeruddin K; Shao R; Balster F; Gardley P; Ashbaugh L
    Int J Neonatal Screen; 2021 May; 7(2):. PubMed ID: 34065072
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical feature, GALC variant spectrum, and genotype-phenotype correlation in Korean Krabbe disease patients: Multicenter experience over 13 years.
    Hwang N; Kim SM; Kim YG; Ha C; Lee J; Choi BO; Sung WJ; Kim SH; Kim YM; Lee YW; Kim J; Kim JW; Jang JH; Lee J; Park HD
    Clin Genet; 2024 Aug; 106(2):150-160. PubMed ID: 38515343
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Late onset Krabbe disease due to the new GALC p.Ala543Pro mutation, with intriguingly high residual GALC activity in vitro.
    Krägeloh-Mann I; Harzer K; Rostásy K; Beck-Wödl S; Bornemann A; Böhringer J; Bevot A; Beck V; Merkel G; Pechan M
    Eur J Paediatr Neurol; 2017 May; 21(3):522-529. PubMed ID: 28109651
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical outcomes of children with abnormal newborn screening results for Krabbe disease in New York State.
    Wasserstein MP; Andriola M; Arnold G; Aron A; Duffner P; Erbe RW; Escolar ML; Estrella L; Galvin-Parton P; Iglesias A; Kay DM; Kronn DF; Kurtzberg J; Kwon JM; Langan TJ; Levy PA; Naidich TP; Orsini JJ; Pellegrino JE; Provenzale JM; Wenger DA; Caggana M
    Genet Med; 2016 Dec; 18(12):1235-1243. PubMed ID: 27171547
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Weighing the evidence for newborn screening for early-infantile Krabbe disease.
    Kemper AR; Knapp AA; Green NS; Comeau AM; Metterville DR; Perrin JM
    Genet Med; 2010 Sep; 12(9):539-43. PubMed ID: 20601893
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Newborn Screening for Krabbe Disease: Status Quo and Recommendations for Improvements.
    Matern D; Basheeruddin K; Klug TL; McKee G; Edge PU; Hall PL; Kurtzberg J; Orsini JJ
    Int J Neonatal Screen; 2024 Jan; 10(1):. PubMed ID: 38390974
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Krabbe disease: clinical, biochemical and molecular information on six new patients and successful retrospective diagnosis using stored newborn screening cards.
    Puckett RL; Orsini JJ; Pastores GM; Wang RY; Chang R; Saavedra-Matiz CA; Torres PA; Zeng B; Caggana M; Lorey F; Abdenur JE
    Mol Genet Metab; 2012 Jan; 105(1):126-31. PubMed ID: 22115770
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.